Skip to main content
Top
Published in: Bulletin of Experimental Biology and Medicine 1/2011

01-05-2011 | Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)

Dynamics of Elimination of Plasmids and Expression of VEGF121 Gene Transfected into Human Mesenchymal Stem Cells by Different Methods

Authors: S. A. Smirnikhina, A. V. Lavrov, N. P. Bochkov

Published in: Bulletin of Experimental Biology and Medicine | Issue 1/2011

Login to get access
Metadata
Title
Dynamics of Elimination of Plasmids and Expression of VEGF121 Gene Transfected into Human Mesenchymal Stem Cells by Different Methods
Authors
S. A. Smirnikhina
A. V. Lavrov
N. P. Bochkov
Publication date
01-05-2011
Publisher
Springer US
Published in
Bulletin of Experimental Biology and Medicine / Issue 1/2011
Print ISSN: 0007-4888
Electronic ISSN: 1573-8221
DOI
https://doi.org/10.1007/s10517-011-1272-5

Other articles of this Issue 1/2011

Bulletin of Experimental Biology and Medicine 1/2011 Go to the issue

Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)

Regularities in the Formation of Structural and Functional Changes in the Brain in Technogenic Stress

Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)

Optimization of a Method for Preparation and Repopulation of the Tracheal Matrix for Allogenic Transplantation

Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)

Cell Technology Employing Femtosecond Laser Pulses

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine